EURETINA 2015 — Stereotactic radiotherapy for treatment of wet AMD in a treat-and-extend regime: first year outcomes
Katja Hatz MD discusses the promising one-year results achieved with Oraya Therapy at her centre in Switzerland.
Oraya Therapy™ Stereotactic Radiotherapy for Wet AMD uses low-energy, highly targeted X-rays to treat wet AMD and is intended as a one-time procedure with the potential to maintain vision while reducing the required number of anti-VEGF injections. Full 2-year results from Oraya's INTREPID study were published in Ophthalmology, January 2015, and real world patient outcomes from three countries were present at EURETINA 15th Congress, September 2015. The Oraya Therapy is available in several treatment centres across Germany, Switzerland, and the United Kingdom.
http://www.orayainc.com/amd-clinical-outcomes/
